New immune drugs target tough liver cancers in major trial

NCT ID NCT05775159

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing whether new immune-boosting drugs, given alone or with other cancer drugs, can help control advanced liver or bile duct cancer. It will enroll about 294 adults whose cancer has spread and is no longer responding to standard treatments. The main goals are to see if the treatments shrink tumors, delay cancer growth, and are safe for patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Birmingham, Alabama, 35233, United States
Research Site
WITHDRAWN

Costa Mesa, California, 92627, United States
Research Site
RECRUITING

Los Angeles, California, 90089, United States
Research Site
RECRUITING

Orange, California, 92868, United States
Research Site
WITHDRAWN

Miami Beach, Florida, 33140, United States
Research Site
WITHDRAWN

Dyer, Indiana, 46311, United States
Research Site
RECRUITING

Kansas City, Kansas, 66103, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
WITHDRAWN

Dallas, Texas, 75251, United States
Research Site
WITHDRAWN

Fairfax, Virginia, 22031, United States
Research Site
RECRUITING

Beijing, 100050, China
Research Site
RECRUITING

Beijing, 100142, China
Research Site
RECRUITING

Beijing, 101100, China
Research Site
RECRUITING

Chengdu, 610000, China
Research Site
RECRUITING

Chengdu, 610041, China
Research Site
RECRUITING

Chongqing, 400030, China
Research Site
RECRUITING

Fuzhou, 350007, China
Research Site
RECRUITING

Guangzhou, 510060, China
Research Site
RECRUITING

Guangzhou, 510515, China
Research Site
RECRUITING

Harbin, 150081, China
Research Site
WITHDRAWN

Hefei, 230001, China
Research Site
WITHDRAWN

Hefei, 230022, China
Research Site
WITHDRAWN

Hefei, 230601, China
Research Site
WITHDRAWN

Nanchang, 330006, China
Research Site
RECRUITING

Nanning, 530021, China
Research Site
WITHDRAWN

Shandong, China
Research Site
RECRUITING

Shanghai, 200032, China
Research Site
WITHDRAWN

Xi'an, 710038, China
Research Site
WITHDRAWN

Zhengzhou, 450008, China
Research Site
RECRUITING

Hong Kong, 999077, Hong Kong
Research Site
RECRUITING

Shatin, 00000, Hong Kong
Research Site
RECRUITING

Florence, 50134, Italy
Research Site
RECRUITING

Milan, 20132, Italy
Research Site
RECRUITING

Naples, 80131, Italy
Research Site
RECRUITING

Rozzano, 20089, Italy
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Kashiwa, 277-8577, Japan
Research Site
RECRUITING

Yokohama, 241-8515, Japan
Research Site
RECRUITING

Seongnam-si, 463-712, South Korea
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
RECRUITING

Seoul, 05505, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Barcelona, 08036, Spain
Research Site
RECRUITING

Barcelona, 8035, Spain
Research Site
RECRUITING

Madrid, 28007, Spain
Research Site
RECRUITING

Madrid, 28040, Spain
Research Site
RECRUITING

Pamplona, 31008, Spain
Research Site
RECRUITING

Kaohsiung City, 80756, Taiwan
Research Site
RECRUITING

Kaohsiung City, 833, Taiwan
Research Site
RECRUITING

Liuying, 736, Taiwan
Research Site
RECRUITING

Taichung, 40705, Taiwan
Research Site
RECRUITING

Tainan, 70403, Taiwan
Research Site
RECRUITING

Taipei, 10002, Taiwan
Research Site
RECRUITING

Taipei, 11259, Taiwan
Research Site
RECRUITING

Taoyuan District, 333, Taiwan
Research Site
RECRUITING

Cambridge, CB2 0QQ, United Kingdom
Research Site
WITHDRAWN

Edinburgh, EH4 2XU, United Kingdom
Research Site
RECRUITING

London, NW3 2QG, United Kingdom
Research Site
RECRUITING

Manchester, M20 4BX, United Kingdom

Conditions

Explore the condition pages connected to this study.

BILIARY TRACT CANCER HEPATOCELLULAR CARCINOMA